NYSE:BSXMedical Equipment
Do Boston Scientific’s (BSX) WATCHMAN Win and Asurys Launch Quietly Recast Its Long-Term Growth Story?
In late March 2026, Boston Scientific announced landmark CHAMPION-AF trial results showing its WATCHMAN FLX left atrial appendage closure device matched non-vitamin K antagonist oral anticoagulants on stroke prevention while reducing clinically relevant bleeding, alongside FDA 510(k) clearance for the Asurys Fluid Management System for endoscopic urologic procedures.
The unusual combination of clinically strong WATCHMAN data and a new kidney-stone-focused irrigation platform with intrarenal...